|
Imciromab pentetate
Product Approval Information - Licensing Action
Proper name: Imciromab pentetate
Tradename: Myoscint
Manufacturer: Centocor B.V., Leiden, The Netherlands, License #1178
Indication for Use: Preparation of Indium In 111 Imciromab pentetate to be used as a cardiac imaging agent for detecting the presence and/or identifying the location of myocardial injury in patients with suspected myocardial infarction
Approval Date: 7/3/96
Type of submission: Biologics license application
Approval Letter (Text)
Summary Basis for Approval (PDF)
Labeling (PDF)
Last Updated: 3/5/2001
 Back
to Top 
Back to Index
Date created: September 24, 2003 |
